{"retracted":false,"update":{"timestamp":1417392000000,"doi":"10.1016/j.clim.2014.11.002","type":"err"},"doi":"10.1016/j.clim.2007.03.512","journal":"Clinical Immunology","publisher":"Elsevier BV","title":"Corrigendum to “T.101. Treatment of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF) and its coned derivative (GcMAFc) eradicates HIV-infection” [Clin. Immunol. 131 (Supplement) (2009) S80]"}
